Table 2.
Variables | Treatment Groups | ||
---|---|---|---|
CF | EF1 | EF2 | |
Gender | |||
Male/Female, n (%) | 33/32 (51/49) | 32/35 (48/52) | 30/33 (48/52) |
Race, n (%) | |||
White | 42 (65) | 45 (67) | 37 (59) |
Black | 15 (23) | 12 (18) | 23 (37) |
Asian | 0 (0) | 1 (1) | 0 (0) |
Pacific Islander | 0 (0) | 1 (1) | 0 (0) |
White/Hispanic | 0 (0) | 1 (1) | 0 (0) |
White/Black | 7 (11) | 6 (9) | 3 (5) |
White/Asian | 0 (0) | 1 (1) | 0 (0) |
Black/Asian | 1 (2) | 0 (0) | 0 (0) |
Gestational Age, weeks * | 39.1 ± 0.1 (65) | 38.9 ± 0.1 (67) | 38.9 ± 0.1 (62) |
Mode of Delivery ** | |||
Vaginal/C-Section, n (%) | 42/20 (68/32) | 54/10 (84/16) | 40/22 (65/35) |
Age at Enrollment, days | 5.3 ± 0.2 (65) | 4.7 ± 0.2 (67) | 5.3 ± 0.2 (63) |
Birth Weight, g | 3382 ± 57 (65) | 3345 ± 52 (67) | 3211 ± 51 (63) |
Birth Length, cm ‡ | 50.3 ± 0.3 (65) | 50.5 ± 0.3 (67) | 49.8 ± 0.2 (63) |
Birth Head Circumference, cm | 33.8 ± 0.4 (35) | 34.0 ± 0.3 (48) | 33.9 ± 0.2 (39) |
Abbreviations: CF = Control formula, EF1 = Experimental formula 1, EF2 = Experimental formula 2; * Values are mean ± SEM (n). No significant differences (p > 0.05); ** Mode of delivery was significantly higher for EF1 versus CF or EF2 (p = 0.013); ‡ Males: CF > EF2 (p = 0.0402; CF = 50.9 ± 0.4 > EF2 = 49.6 ± 0.4).